P. Schaefer Price
Directeur/Membre du Conseil chez Arbutus Biopharma, Inc.
Profil
P.
Schaefer Price is currently a Director at Arbutus Biopharma, Inc. Prior to this, he was the President, Chief Executive Officer & Director at Pharmasset, Inc. from 2011 to 2012.
He was also the Managing Director at Lakeshore Bioventures from 2001 to 2002.
Earlier in his career, he served as Vice President at Burrill & Craves and as President at PowderJect Vaccines, Inc. from 1997 to 2001.
Mr. Price received his undergraduate degree from the University of Wisconsin and his MBA from the University of Minnesota.
Postes actifs de P. Schaefer Price
| Sociétés | Poste | Début |
|---|---|---|
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Directeur/Membre du Conseil | 01/08/2014 |
Anciens postes connus de P. Schaefer Price
| Sociétés | Poste | Fin |
|---|---|---|
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | President | 12/01/2012 |
| Lakeshore Bioventures | Corporate Officer/Principal | 01/09/2002 |
| PowderJect Vaccines, Inc. | President | 01/07/2001 |
| Burrill & Craves | Corporate Officer/Principal | - |
Formation de P. Schaefer Price
| University of Wisconsin | Undergraduate Degree |
| University of Minnesota | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Health Technology |
| Burrill & Craves | |
| PowderJect Vaccines, Inc. | |
| Lakeshore Bioventures |
